Dear all, I am putting together a business case for R and I would like to know if there exist statistics on the distribution of R in academia, research and commercial institutions. The same information about S-plus would be welcome. Please reply only if you have consistent and certain information. Thank you very much, giovanni
giovanni merola wrote:> Dear all, > I am putting together a business case for R and I would like to know if > there exist statistics on the distribution of R in academia, research > and commercial institutions. The same information about S-plus would be > welcome. Please reply only if you have consistent and certain information. >For the usual commercial reasons, getting hard data about commercial use is difficult. I've usually just listed the customers' needs (compatibility? particular OS/platform as standard? extensibility? support?), and compared the strengths and weaknesses of R vs. other apps. Cheers Jason
My humble idea from perspective of a "market researcher". Counting the different mail-adresses with *.com in the help-archives of the last years (nice Text-Mining-Archive) with a bot. Ok, perhaps somebody like me use a freemail, so it's biased ,too. Reasons may be different - my is a technical one. christian Am Freitag, 12. M?rz 2004 11:16 schrieb giovanni merola:> Dear all, > I am putting together a business case for R and I would like to know if > there exist statistics on the distribution of R in academia, research > and commercial institutions. The same information about S-plus would be > welcome. Please reply only if you have consistent and certain information. > > Thank you very much, giovanni > > ______________________________________________ > R-help at stat.math.ethz.ch mailing list > https://www.stat.math.ethz.ch/mailman/listinfo/r-help > PLEASE do read the posting guide! > http://www.R-project.org/posting-guide.html
> > Just to be provocative, it would be best to state the ultimate goals, then > R users could be of more help. We have submitted and published articles > using R and are using R in production work on contracts from > pharmaceutical companies. It's difficult to know from the original note > why we should spend time compiling such data. Is anyone finding that R > has some deficiencies with respect to their own work? >All the analysis I do is done with R, so anything published where I am in the author list is likely to have been done/revised with R. The fact than R requires me to know what I am doing is more of an advantage, IMHO, rather than a shortcoming... from a usability standpoint I never felt I had any problem I could not deal with after some thinking, or asking the list. Regards, Federico Calboli -- ================================ Federico C. F. Calboli Dipartimento di Biologia Via Selmi 3 40126 Bologna Italy tel (+39) 051 209 4187 fax (+39) 051 251 4286 f.calboli at ucl.ac.uk